What physicians should know about FDA's new proposed guidance ...
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study We divided the borrowing ...
Extended educational sessions that offer attendees the opportunity to learn research methods and techniques from prominent ...